SCHEMBL6315510

SCHEMBL6315510

CS(=O)(=O)Nc1onc(-c2ccccn2)c1C(N)=O.c1cc2cc-2c1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 1/20 0.40
GAA P10253 1/20 0.40
KMT2A Q03164 1/20 0.40
RET P07949 1/20 0.40
EDNRA P25101 5/20 0.38
EDNRB P24530 4/20 0.38
KAT6A Q92794 1/20 0.36
SQOR Q9Y6N5 1/20 0.36
PIK3CD O00329 1/20 0.36
GRM5 P41594 3/20 0.35
CSNK1D P48730 1/20 0.35
CSNK1E P49674 1/20 0.35
CHEK2 O96017 1/20 0.35
CHUK O15111 2/20 0.35
IKBKB O14920 1/20 0.35
INSR P06213 1/20 0.35
MAPK8 P45983 1/20 0.35
CAMKK2 Q96RR4 1/20 0.35
NPC1 O15118 1/20 0.34
MITF O75030 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6318219 0.93 EDNRA (0.42) MEN1GAAKMT2ARETEDNRA
SCHEMBL6317664 0.90 EDNRA (0.40) EDNRAEDNRBKAT6APIK3CDGRM5
SCHEMBL6316907 0.83 EDNRA (0.43) MEN1KMT2AEDNRAEDNRB
SCHEMBL6317676 0.81 EDNRA (0.46) MEN1GAAKMT2AEDNRAEDNRB
SCHEMBL6323782 0.80 EDNRA (0.48) MEN1GAAKMT2AEDNRAEDNRB
SCHEMBL6319065 0.79 MEN1 (0.40) MEN1GAAKMT2ARETEDNRA
SCHEMBL6317766 0.78 EDNRA (0.38) GAARETEDNRAEDNRBGRM5
SCHEMBL6315506 0.77 GLO1 (0.40) MEN1GAAKMT2ARETEDNRA
SCHEMBL6315903 0.77 KDM4E (0.50) MEN1GAAKMT2ARETEDNRA
SCHEMBL6316055 0.76 KDM4E (0.56) MEN1GAAKMT2AMAPTPKM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050059657-A1 Aminoisoxazole derivatives active as kinase inhibitors PFIZER ITALIA S.R.L. (IT) 2005-03-17 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050059657-A1 Aminoisoxazole derivatives active as kinase inhibitors MAP3K9, MAP3K19, MAP4K2 MEN1 2789/4885GAA 789/4885KMT2A 1089/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.